RxDoctor Payments Data

Robert Neal

Optometrist · Maple Valley, WANPI 1376632539

Payments from drug & device makers

$3,185in general payments, 2019–2025

Across 77 payments — averaging $41.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopervision Inc.$2K
  • Alcon$966
  • Optos, Inc.$248
  • AbbVie$190
  • Bausch & Lomb Americas Inc.$101
  • Biotissue Holdings Inc.$52

What the payments were for

  • Food & beverage$2,58881%
  • Education$50016%
  • Entertainment$973%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Coopervision Inc.38$1,629
Alcon30$966
Optos, Inc.2$248
AbbVie(2 entities)3$190
Bausch & Lomb Americas Inc.1$101
Biotissue Holdings Inc.3$52

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,185 in reported general payments places this provider in the 90th percentile of 1,267 optometrist providers in Washington.

See all optometrist providers in Washington

Medicare billing

Part B allowed, 2024
$55,002
Medicare patients
250
Services billed
566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Travoprost18$1,465
Latanoprost79$797
Prednisolone Acetate18$492
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat12$310
Timolol Maleate26$288

Paid to pharmacies, not to this prescriber.

Other optometrist in Maple Valley

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →